
About Saarum Sciences Private Limited
Data last updated:
Saarum Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Saarum Innovations Private Limited. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 12 February 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2011PTC072564. Its GSTIN is 36AAPCS3891K1ZK (Telangana).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.02 Lakh. It is led by directors Sreevatsa Natarajan Gopinath and Jugnu Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 8 – 2 – 293/82/J – III/Dh/900 1st Floor Aherf Building Apollo Hospitals Jubilee Hills, Hyderabad, Telangana, India – 500096.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.89 Lakh, a decline of 49% compared to the previous year. For the same year it recorded a net loss of ₹13,649 (net margin -7.2%) and EBITDA of ₹1.16 Lakh (EBITDA margin 61.6%). Revenue has declined at a compounded annual rate (CAGR) of 61% over three years and 44% over five years.
The company is associated with 1 brand: Saarum Sciences.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website saarum.co.in.
Company details
CIN history
Saarum Sciences has one previous CIN (Corporate Identification Number): U24232AP2011PTC072564. The current CIN is U24232TG2011PTC072564, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2011PTC072564 | Current |
| U24232AP2011PTC072564 | Previous |
Contact details
Saarum Sciences Private Limited's registered office is in Hyderabad, Telangana. Its website is saarum.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address8 – 2 – 293/82/J – III/Dh/900 1st Floor Aherf Building Apollo Hospitals Jubilee Hills, Hyderabad, Telangana, India – 500096
- IndustryLife Sciences, Biotechnology
To see the full contact details of Saarum Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Saarum Sciences operates one associated brand: Saarum Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Biotechnology services focused on drug discovery platforms and research collaborations. | saarum.co.in |
Financials of Saarum Sciences Private Limited
FY 2025 filings availableSaarum Sciences Private Limited reported revenue of ₹1.89 Lakh (down 49% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 44% over five years, including a 49% fall in the latest year. EBITDA rose 137% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.16 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹13,649 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 61.6% | ||||
| Net Profit Margin | -7.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Saarum Sciences Private Limited, buy the company report.
Board of directors of Saarum Sciences Private Limited
Saarum Sciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sreevatsa Natarajan Gopinath Also directs: Anpv Farms & Resorts LLP, Dyuloka Resorts LLP, Sapien Biosciences Private Limited and 1 more | Director | 12 Feb 2011 | 15 Years 9 Months | Current |
| Jugnu Jain | Director | 11 Oct 2012 | 14 Years 1 Months | Current |
Peer comparison
Saarum Sciences Private Limited is compared with the 4 companies closest to it by revenue in the Biotechnology industry (Biotechnology), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alicorn Medical Private Limited | ₹2.1 Lakh (FY 2025) | Thiruvananthapuram, Kerala, India | ||||
| Applied Dna Sciences India Private Limited | ₹2.08 Lakh (FY 2025) | -97.0% | Ahmedabad, Gujarat, India | |||
| Nath Bio-Technologies Limited | ₹2.02 Lakh (FY 2025) | Aurangabad, Maharashtra, India | ||||
| Saarum Sciences Private Limitedthis company | ₹1.89 Lakh (FY 2024) | -₹13,649 | -7.2% | -49.0% | Hyderabad, Telangana, India | |
| Italab Salem Private Limited | ₹1.75 Lakh (FY 2019) | -60.0% | Salem, Tamil Nadu, India |
To see the full peer comparison of Saarum Sciences Private Limited, buy the company report.
Auditor
Saarum Sciences Private Limited is audited by J D P & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J D P & CO | FY 2020 | 019550S |
Shareholding
The shareholding of Saarum Sciences Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Saarum Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Saarum Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Saarum Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Saarum Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAPCS3891K1ZK | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Saarum Sciences Private Limited, buy the company report.
Recent activity
Saarum Sciences Private Limited has 5 board changes on record since 2011: 2 appointments and 3 cessations. The latest: Sreevatsa Natarajan Gopinath ceased to be Managing Director on 18 Mar 2019.
Frequently asked questions
Saarum Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 12 February 2011 (15+ years old) and is registered under CIN U24232TG2011PTC072564.
Saarum Sciences has 2 current directors:
- Sreevatsa Natarajan Gopinath - Director
- Jugnu Jain - Director
The latest financial statements of Saarum Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Saarum Sciences is 36AAPCS3891K1ZK, registered in Telangana.
The CIN (Corporate Identification Number) of Saarum Sciences is U24232TG2011PTC072564. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Saarum Sciences was incorporated on 12 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Saarum Sciences by revenue are Alicorn Medical Private Limited, Applied Dna Sciences India Private Limited, Nath Bio-Technologies Limited, Italab Salem Private Limited, all in the Biotechnology industry (Biotechnology), with the same principal business activity (scientific research and development).
Sreevatsa Natarajan Gopinath ceased to be Managing Director on 18 Mar 2019. Prithi Rajan ceased to be Director on 28 Jun 2014. Vidya Shridhar ceased to be Director on 03 Nov 2012. Saarum Sciences has 5 board changes on record in total.
Saarum Sciences can be reached through the website saarum.co.in. Its registered office is in Hyderabad, Telangana, India.
The registered office of Saarum Sciences is at 8 – 2 – 29382J – IIIDh900 1st Floor Aherf Building Apollo Hospitals Jubilee Hills, Hyderabad, Telangana, India – 500096.
Saarum Sciences operates in the life sciences industry, in the biotechnology segment.

